/index.php?option=com_iwpfile&file=/dir_01/he2002_2462.pdf

/index.php?option=com_iwpfile&file=/dir_01/he2002_2461.pdf

/index.php?option=com_iwpfile&file=/dir_01/he2002_2460.pdf

In a statement, OSHA Administrator John Henshaw praises the American Furniture Manufacturers Association and the North Carolina Department of Labor for their alliance designed to develop voluntary ergonomic guidelines. The alliance is the first of its kind, bringing federal and state government together with industry to develop voluntary ergonomics guidelines for a specific industry.


HHS Secretary Tommy Thompson calls on drug companies to make pharmaceuticals more affordable in a recent speech at the 15th annual Bear, Stearns Healthcare Conference.


Normal" style=" text-align: center;">Statement on Safety Issues Related to Acetaminophen

Before the Nonprescription Drugs Advisory Committee

September 19, 2002

In 1977, the Food and Drug Administration's (FDA's) Advisory Review Panel recommended the following warnings for acetaminophen-containing products: "Do not exceed recommended dosage because severe liver damage may occur" and "Do not exceed recommended dosage or take for more than 10 days, because severe liver damage may occur." The FDA chose to ignore this wise advice.


/index.php?option=com_iwpfile&file=/dir_01/he2002_2456.pdf


A recent telephone poll commissioned by Pfizer, Inc. reveals that the inability to understand prescription medication information leads to poor health outcomes. Among physicians and pharmacists polled, two-thirds encounter patients not understanding prescription directions. The study was released at this week's Fifth Annual Pfizer Health Literacy Conference. Click here for Pfizer Release


In comments on the HHS Strategic Plan for fiscal years 2003-2008, the American Hospital Association calls on HHS to address the increasing shortage of personnel in health care. Click here for AHA Comments


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.